Stay informed with the latest litigation news. Explore now

Point-Of-Care And/Or Portable Platform For Gene Therapy - EP3247808B1

EP3247808

FRED HUTCHINSON CANCER RESEARCH CENTER
Application Number
EP16740786A
Filing Date
Jan 21, 2016
Status
Revoked
Jan 26, 2024
Grant Date
May 5, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP3247808B1 was granted to Fred Hutchinson Cancer Research Center on May 5, 2021 following the initial filing on Jan 21, 2016 under the application number EP16740786A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANFeb 3, 2022ADMISSIBLE
MILTENYI BIOTECFeb 1, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents